Allergan plc, a global pharmaceutical company announced topline data from a phase II study with major depressive disorder (MDD). The study evaluated the efficacy, safety and tolerability of a single administration
Tag "Botox"
Botox maker Allergan said it would buy body-contouring product maker Zeltiq Aesthetics for about $2.48 billion (€2.34 billion), adding muscle to its line-up of products used to fight fat and
Advertisements
